BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11349829)

  • 1. Histone deacetylase inhibitors promote apoptosis and differential cell cycle arrest in anaplastic thyroid cancer cells.
    Greenberg VL; Williams JM; Cogswell JP; Mendenhall M; Zimmer SG
    Thyroid; 2001 Apr; 11(4):315-25. PubMed ID: 11349829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Butyrate alters the expression and activity of cell cycle components in anaplastic thyroid carcinoma cells.
    Greenberg VL; Williams JM; Boghaert E; Mendenhall M; Ain KB; Zimmer SG
    Thyroid; 2001 Jan; 11(1):21-9. PubMed ID: 11272092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trichostatin A, an inhibitor of histone deacetylases, strongly suppresses growth of pancreatic adenocarcinoma cells.
    Donadelli M; Costanzo C; Faggioli L; Scupoli MT; Moore PS; Bassi C; Scarpa A; Palmieri M
    Mol Carcinog; 2003 Oct; 38(2):59-69. PubMed ID: 14502645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deacetylase inhibition in malignant melanomas: impact on cell cycle regulation and survival.
    Flørenes VA; Skrede M; Jørgensen K; Nesland JM
    Melanoma Res; 2004 Jun; 14(3):173-81. PubMed ID: 15179185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase inhibition-mediated post-translational elevation of p27KIP1 protein levels is required for G1 arrest in fibroblasts.
    Chen JS; Faller DV
    J Cell Physiol; 2005 Jan; 202(1):87-99. PubMed ID: 15389542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of p21(WAF1/CIP1) by histone deacetylase inhibitors reduces their cytotoxicity.
    Burgess AJ; Pavey S; Warrener R; Hunter LJ; Piva TJ; Musgrove EA; Saunders N; Parsons PG; Gabrielli BG
    Mol Pharmacol; 2001 Oct; 60(4):828-37. PubMed ID: 11562446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of trichostatin A, a histone deacetylase inhibitor, on glioma proliferation in vitro by inducing cell cycle arrest and apoptosis.
    Wetzel M; Premkumar DR; Arnold B; Pollack IF
    J Neurosurg; 2005 Dec; 103(6 Suppl):549-56. PubMed ID: 16383255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1 1.
    Rosato RR; Almenara JA; Grant S
    Cancer Res; 2003 Jul; 63(13):3637-45. PubMed ID: 12839953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel heat shock protein 90 inhibitor NVP-AUY922 synergizes with the histone deacetylase inhibitor PXD101 in induction of death of anaplastic thyroid carcinoma cells.
    Kim SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ
    J Clin Endocrinol Metab; 2015 Feb; 100(2):E253-61. PubMed ID: 25389633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase inhibitors increase p21(WAF1) and induce apoptosis of human myeloma cell lines independent of decreased IL-6 receptor expression.
    Lavelle D; Chen YH; Hankewych M; DeSimone J
    Am J Hematol; 2001 Nov; 68(3):170-8. PubMed ID: 11754398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of histone deacetylase arrest cell cycle and induce apoptosis in cervical carcinoma cells circumventing human papillomavirus oncogene expression.
    Finzer P; Kuntzen C; Soto U; zur Hausen H; Rösl F
    Oncogene; 2001 Aug; 20(35):4768-76. PubMed ID: 11521189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carfilzomib potentiates CUDC-101-induced apoptosis in anaplastic thyroid cancer.
    Zhang L; Boufraqech M; Lake R; Kebebew E
    Oncotarget; 2016 Mar; 7(13):16517-28. PubMed ID: 26934320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors.
    Pei XY; Dai Y; Grant S
    Clin Cancer Res; 2004 Jun; 10(11):3839-52. PubMed ID: 15173093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites.
    Sowa Y; Orita T; Minamikawa S; Nakano K; Mizuno T; Nomura H; Sakai T
    Biochem Biophys Res Commun; 1997 Dec; 241(1):142-50. PubMed ID: 9405248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Regulation of histone acetylation on the expression of cell cycle-associated genes in human colon cancer cell lines].
    Chen YX; Fang JY; Lu J; Qiu DK
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):312-7. PubMed ID: 15059516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trichostatin inhibits the growth of ACHN renal cell carcinoma cells via cell cycle arrest in association with p27, or apoptosis.
    Park WH; Jung CW; Park JO; Kim K; Kim WS; Im YH; Lee MH; Kang WK; Park K
    Int J Oncol; 2003 May; 22(5):1129-34. PubMed ID: 12684681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel histone deacetylase inhibitor thailandepsin A inhibits anaplastic thyroid cancer growth.
    Weinlander E; Somnay Y; Harrison AD; Wang C; Cheng YQ; Jaskula-Sztul R; Yu XM; Chen H
    J Surg Res; 2014 Jul; 190(1):191-7. PubMed ID: 24679699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of a functional role for p21WAF1/CIP1 down-regulation in synergistic antileukemic interactions between the histone deacetylase inhibitor sodium butyrate and flavopiridol.
    Rosato RR; Almenara JA; Yu C; Grant S
    Mol Pharmacol; 2004 Mar; 65(3):571-81. PubMed ID: 14978235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic growth inhibition of prostate cancer cells by 1 alpha,25 Dihydroxyvitamin D(3) and its 19-nor-hexafluoride analogs in combination with either sodium butyrate or trichostatin A.
    Rashid SF; Moore JS; Walker E; Driver PM; Engel J; Edwards CE; Brown G; Uskokovic MR; Campbell MJ
    Oncogene; 2001 Apr; 20(15):1860-72. PubMed ID: 11313934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone acetylation may suppress human glioma cell proliferation when p21 WAF/Cip1 and gelsolin are induced.
    Kamitani H; Taniura S; Watanabe K; Sakamoto M; Watanabe T; Eling T
    Neuro Oncol; 2002 Apr; 4(2):95-101. PubMed ID: 11916500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.